1LIU H W’KWONG Y L,BOURKE C,et al. High in-cidence of thrombophilia detected in Chinese patientswith venous thrombosis[J]. Thromb Haemost, 1994,71 :416-419.
2SHEN M C,UN J S,TSAY W. High prevalence ofantithromb III,protein C and protein S deficiency,butno factor V Leiden mutation in venous thrombophilicChinese patients in Taiwan[J]. Thromb Res,1997,87:377-385.
5LIJFERING W M,BROUWER J L’VEEGER N J,etal. Selective testing for thrombophilia in patients withfirst venous thrombosis: results from a retrospectivefamily cohort study on absolute thrombotic risk forcurrently known thrombophilic defects in 2 479 rela-tives[J]. Blood,2009,113:5314-5322.
6MIYAKIS S’LOCKSHIN M D,ATSUMI T,et al. In-ternational consensus statement on an update of theclassification criteria for definite antiphospholipidsyndrome (APS) [J], J Thromb Haemost,2006,4 :295 - 306.
7KEELING D,MACKIE I,MOORE G W,et al. Guide-lines on the investigation and management of an-tiphospholipid syndrome [J]. Br J Haematol,2012,157:47-58.
8SMALBERG J H,KRUIP M J JANSSEN H L,et al.Hypercoagulability and hypofibrinolysis and risk ofdeep vein thrombosis and splanchnic vein thrombosis:similarities and differences [J]. Arterioscler ThrombVase Biol,2011 .31:485 -493.
9DENTALI F, SQUIZZATO A,BRIVIO L, et al.JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venousthromboembolism: a meta-analysis [J]. Blood,2009,113:5617-5623.
